Johnson & Johnson Share Price (NYSE: JNJ)

$177.18

▲

1.73

(0.99%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Johnson & Johnson Stock chart to analyse performance

Johnson & Johnson stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$175.63
Today's High:$177.39
$177.18
0.87%
Downside
Day's Volatility :0.99%
Upside
0.12%
52 Weeks Low:$140.68
52 Weeks High:$181.16
$177.18
20.6%
Downside
52 Weeks Volatility :22.34%
Upside
2.2%

Johnson & Johnson Stock Returns

Period	Johnson & Johnson	Sector (Health Care)	Index (NASDAQ Composite)
3 Months	14.0%	3.6%	7.7%
6 Months	5.91%	-7.7%	3.9%
1 Year	6.81%	-12.6%	9.6%
3 Years	9.81%	9.5%	43.3%

Johnson & Johnson Key Stats

Check Johnson & Johnson key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$175.45
Open	$175.965
Today's High	$177.39
Today's Low	$175.63
Market Capitalization	$426.7B
Today's Volume	$6.9M
52 Week High	$181.16
52 Week Low	$140.68
Revenue TTM	$90.6B
EBITDA	$30.3B
Earnings Per Share (EPS)	$9.34
PE Ratio	18.97
Dividend Yield	2.86%
Profit Margin	25.0%
Quarterly Earnings Growth YOY	0.19%
Return On Equity TTM	30.21%

Stock Returns calculator for Johnson & Johnson Stock including INR - Dollar returns

The Johnson & Johnson stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Johnson & Johnson investment value today

Current value as on today

₹1,12,109

Returns

₹12,109

(+12.11%)

Returns from Johnson & Johnson Stock

₹6,825 (+6.83%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Johnson & Johnson Stock

-12.71%

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Investment in Johnson & Johnson Shares from India has dropped by -12.71% over the past 30 days, indicating reduced transactional activity.

-13%

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Search interest for Johnson & Johnson Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Johnson & Johnson Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	19449	-739.65	0.73%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	3800	0.00	3.31%

Global Institutional Holdings in Johnson & Johnson

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
9.84%
BlackRock Inc
8.28%
State Street Corp
5.56%
Geode Capital Management, LLC
2.47%
JPMorgan Chase & Co
2.24%
Morgan Stanley - Brokerage Accounts
1.91%

Analyst Recommendation on Johnson & Johnson Stock

Rating

Trend

Buy

53%Buy

46%Hold

0%Sell

Based on 28 Wall street analysts offering stock ratings for Johnson & Johnson(by analysts ranked 0 to 5 stars)

Johnson & Johnson Share Price Target

What analysts predicted

Downside of 0.33%

Target:

$176.60

Current:

$177.18

Johnson & Johnson share price target is $176.60, a slight Downside of 0.33% compared to current price of $177.18 as per analysts' prediction.

Johnson & Johnson Stock Insights

Price Movement
In the last 7 days, JNJ stock has moved down by -1.2%
Increasing Revenue
Johnson & Johnson has shown positive revenue growth over the last two quarters. The revenue increased from $21.89 billion to $23.74 billion, reflecting an average increase of 7.8% per quarter.
Decreasing Net Profit
Johnson & Johnson's net profit has decreased for the last two quarters. It fell from $10.99 billion to $5.53 billion, showing an average decrease of 49.7% per quarter.
JNJ vs PG (3 yr)
In the last 3 years, Procter & Gamble Company, The has given 12.0% return, outperforming this stock by 2.9%

Johnson & Johnson Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$82.1B	↑ 0.59%
Net Income	$15.1B	↓ 1.16%
Net Profit Margin	18.42%	↓ 0.33%

	FY20	Y/Y Change
Revenue	$82.6B	↑ 0.64%
Net Income	$14.7B	↓ 2.68%
Net Profit Margin	17.82%	↓ 0.6%

	FY21	Y/Y Change
Revenue	$78.7B	↓ 4.65%
Net Income	$20.9B	↑ 41.89%
Net Profit Margin	26.52%	↑ 8.7%

	FY22	Y/Y Change
Revenue	$80.0B	↑ 1.59%
Net Income	$17.9B	↓ 14.07%
Net Profit Margin	22.43%	↓ 4.09%

	FY23	Y/Y Change
Revenue	$85.2B	↑ 6.46%
Net Income	$35.2B	↑ 95.94%
Net Profit Margin	41.28%	↑ 18.85%

	FY24	Y/Y Change
Revenue	$88.8B	↑ 4.3%
Net Income	$14.1B	↓ 59.99%
Net Profit Margin	15.84%	↓ 25.44%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$21.4B	↓ 0.06%
Net Income	$3.3B	↓ 19.61%
Net Profit Margin	15.22%	↓ 3.7%

	Q2 FY24	Q/Q Change
Revenue	$22.4B	↑ 4.98%
Net Income	$4.7B	↑ 43.96%
Net Profit Margin	20.88%	↑ 5.66%

	Q3 FY24	Q/Q Change
Revenue	$22.5B	↑ 0.11%
Net Income	$2.7B	↓ 42.51%
Net Profit Margin	11.99%	↓ 8.89%

	Q4 FY24	Q/Q Change
Revenue	$22.5B	↑ 0.22%
Net Income	$3.4B	↑ 27.36%
Net Profit Margin	15.24%	↑ 3.25%

	Q1 FY25	Q/Q Change
Revenue	$21.9B	↓ 2.78%
Net Income	$11.0B	↑ 220.58%
Net Profit Margin	50.24%	↑ 35.0%

	Q2 FY25	Q/Q Change
Revenue	$23.7B	↑ 8.45%
Net Income	$5.5B	↓ 49.66%
Net Profit Margin	23.32%	↓ 26.92%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$54.5B	↑ 0.02%

	FY20	Y/Y Change
Profit	$54.2B	↓ 0.63%

	FY21	Y/Y Change
Profit	$55.3B	↑ 2.18%

	FY22	Y/Y Change
Profit	$55.4B	↑ 0.1%

	FY23	Y/Y Change
Profit	$58.4B	↑ 5.45%

	FY24	Y/Y Change
Profit	$61.4B	↑ 5.03%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$14.9B	↑ 1.88%

	Q2 FY24	Q/Q Change
Profit	$15.6B	↑ 4.75%

	Q3 FY24	Q/Q Change
Profit	$15.5B	↓ 0.45%

	Q4 FY24	Q/Q Change
Profit	$15.4B	↓ 0.75%

	Q1 FY25	Q/Q Change
Profit	$14.5B	↓ 5.56%

	Q2 FY25	Q/Q Change
Profit	$16.1B	↑ 10.86%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$23.4B	↑ 5.47%
Investing Cash Flow	$-6.2B	↑ 95.58%
Financing Cash Flow	$-18.0B	↓ 2.67%

	FY20	Y/Y Change
Operating Cash Flow	$23.5B	↑ 0.51%
Investing Cash Flow	$-20.8B	↑ 236.21%
Financing Cash Flow	$-6.1B	↓ 66.03%

	FY21	Y/Y Change
Operating Cash Flow	$23.4B	↓ 0.54%
Investing Cash Flow	$-8.7B	↓ 58.3%
Financing Cash Flow	$-14.0B	↑ 129.53%

	FY22	Y/Y Change
Operating Cash Flow	$21.2B	↓ 9.47%
Investing Cash Flow	$-12.4B	↑ 42.47%
Financing Cash Flow	$-8.9B	↓ 36.85%

	FY23	Y/Y Change
Operating Cash Flow	$22.8B	↑ 7.54%
Investing Cash Flow	$878.0M	↓ 107.1%
Financing Cash Flow	$-15.8B	↑ 78.39%

	FY24	Y/Y Change
Operating Cash Flow	$24.3B	↑ 6.47%
Investing Cash Flow	$-18.6B	↓ 2218.34%
Financing Cash Flow	$-3.1B	↓ 80.21%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$3.7B	↓ 53.49%
Investing Cash Flow	$-464.0M	↓ 61.4%
Financing Cash Flow	$546.0M	↓ 111.73%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$5.6B	↑ 54.03%
Investing Cash Flow	$-13.7B	↑ 2849.78%
Financing Cash Flow	$7.5B	↑ 1281.68%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$8.0B	↑ 41.9%
Investing Cash Flow	$-3.1B	↓ 77.15%
Financing Cash Flow	$-9.9B	↓ 230.99%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$7.0B	↓ 12.64%
Investing Cash Flow	$-1.3B	↓ 57.8%
Financing Cash Flow	$-1.3B	↓ 86.44%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$4.2B	↓ 40.23%
Investing Cash Flow	$-297.0M	↓ 77.5%
Financing Cash Flow	$10.4B	↓ 877.76%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$3.9B	↓ 7.09%
Investing Cash Flow	$-18.3B	↑ 6049.49%
Financing Cash Flow	$-5.7B	↓ 154.36%

Johnson & Johnson Technicals Summary

Sell

Neutral

Buy

Johnson & Johnson is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Johnson & Johnson Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Johnson & Johnson	7.54%	5.91%	6.81%	9.81%	15.48%
Procter & Gamble Company, The	4.37%	-10.56%	-8.45%	13.85%	13.53%
Pfizer Inc.	6.29%	-5.7%	-14.67%	-45.27%	-34.49%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Johnson & Johnson	18.97	18.97	1.07	10.85	0.3	0.08	0.03	32.6
Procter & Gamble Company, The	24.12	24.12	3.77	6.78	0.31	0.11	0.03	21.88
Pfizer Inc.	13.02	13.02	0.83	3.07	0.12	0.05	0.07	15.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Johnson & Johnson	Buy	$426.7B	15.48%	18.97	25.0%
Procter & Gamble Company, The	Buy	$367.8B	13.53%	24.12	18.95%
Pfizer Inc.	Hold	$139.9B	-34.49%	13.02	16.84%

Johnson & Johnson Dividend announcements

Johnson & Johnson Dividends September, 2025
In the quarter ending September,2025. Johnson & Johnson has declared dividend of $1.30

About Johnson & Johnson

Johnson & Johnson - a multinational corporation founded in America - mainly caters to medical and consumer goods. The company's headquarters are in New Jersey, United States. The company was incorporated in 1886 by James, Robert, and Edward Mead Johnson. Johnson & Johnson is one of the world's most valuable corporations. It has nearly 250 subsidiary companies operating across 60 countries. Its products are selling in over 175 countries. Some well-known consumer products of Johnson & Johnson are Band-Aids, baby products, Tylenol medications, and other products. In 2020, Johnson & Johnson generated annual revenue of $82.584 billion. Joaquin Duato serves as the Chairman and CEO for Johnson & Johnson, along with Paul Stoffels as Vice Chairman of the Executive Committee for the company with several other members. The company was ranked 36 on the Fortune 500 list of the top corporations in the United States by total revenue in 2021. Johnson & Johnson is publicly traded on New York Stock Exchange as JNJ as its stock symbol, under the DJIA, S&P 100, and S&P 500. Currently Johnson & Johnson has a market cap of $395.34 Billion. It has a P.E ratio of 10.4. The shares of Johnson & Johnson are trading at $177.16. .

Organization	Johnson & Johnson
Employees	138100
CEO	Mr. Joaquin Duato
Industry	Health Technology

Key Management of Johnson & Johnson

Name	Title
Mr. Joaquin Duato	CEO & Chairman
Mr. Joseph J. Wolk CPA	Executive VP & CFO
Ms. Jennifer L. Taubert	Executive VP & Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D.	Executive Vice President of Innovative Medicine, R&D
Mr. Timothy Schmid	Executive VP & Worldwide Chairman of MedTech
Mr. Robert J. Decker Jr.	Controller & Chief Accounting Officer
Mr. James Swanson	Executive VP & Chief Information Officer
Mr. Darren Snellgrove	Vice President of Investor Relations
Mr. Dirk Brinckman	Chief Compliance Officer
Ms. Elizabeth Forminard J.D.	Executive VP & Chief Legal Officer

Important FAQs about investing in JNJ Stock from India :

What is Johnson & Johnson share price today?

Johnson & Johnson share price today is $177.18 as on August 30, 2025 at 1:29 am IST at the close of the market. Johnson & Johnson share today touched a day high of $177.39 and a low of $175.63.

What is the 52 week high and 52 week low for Johnson & Johnson share?

Johnson & Johnson share touched a 52 week high of $181.16 and a 52 week low of $140.68. Johnson & Johnson stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $177.18, lower by 2.2% versus the 52 week high.

How to invest in Johnson & Johnson Stock (JNJ) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Johnson & Johnson on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Johnson & Johnson Shares that will get you 0.0085 shares as per Johnson & Johnson share price of $177.18 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Johnson & Johnson Stock (JNJ) from India?

Indian investors can start investing in Johnson & Johnson (JNJ) shares with as little as ₹88.286 or $1 (as of August 30, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Johnson & Johnson stock (as per the Rupee-Dollar exchange rate as on August 30, 2025). Based on Johnson & Johnson share’s latest price of $177.18 as on August 30, 2025 at 1:29 am IST, you will get 0.0564 shares of Johnson & Johnson. Learn more about fractional shares .

What are the returns that Johnson & Johnson has given to Indian investors in the last 5 years?

Johnson & Johnson stock has given 15.48% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?